CPHI (China Pharma Holdings, Inc.) מחיר לרווח עתידי

לוגו גרפי של China Pharma Holdings (CPHI)

Government procurement in China is reducing generic drug margins, weakening the market position of China Pharma Holdings (CPHI). However, stable cash flow is maintained through legacy CNS medications. The mass production of anti-infective and antipsychotic drugs at the company's own plants is confirmed by the projected P/E ratio chart for China Pharma Holdings (CPHI), where the indicator settled at 0.00.

שווי שוק לרווח חזוי: China Pharma Holdings, Inc. (CPHI) עבור 04.07.2022 - 18.11.2026

פילוחי מדדים ואנליטיקה של חברת China Pharma Holdings (CPHI)

הערכת שווי פונדמנטלית:CPHI China Pharma Holdings, Inc.
פריט של המותג China Pharma

This indicator compares the projected business value with the issuer's actual ability to generate cash flow for debt service, excluding subjective management forecasts. By analyzing the future P/E NTM of China Pharma Holdings (CPHI), an investor can see how the robotization of generic production and warehouse automation at China Pharma Holdings (CPHI) reduce costs, directly converting technological efficiency into the fundamental undervaluation or overvaluation of the asset.